6月23日，Hims & Hers Health夜盘下跌5.01%，报31.86美元/股，成交额272.1万美元。
消息面上，公司近日提交了拟议出售证券的相关公告，叠加此前一周股价从约28.91美元连续攀升至约35.47美元，累计涨幅显著，潜在股份减持信号引发市场获利回吐压力。尽管巴克莱此前将公司目标价从29美元上调至39美元并维持"增持"评级，但短期减持预期仍主导盘面情绪。
Hims & Hers Health Inc是一家多专业远程医疗平台，将消费者与持牌医疗保健专业人员联系起来，使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.